We caught up with our Editorial Board member, Angelo Antonini (University of Padova, Veneto, Italy), to discuss the neurological and psychiatric events that have been observed in patients with COVID-19, what could be done to prepare for these and if anything can be learnt from current experience.
1. Could you tell us about the neurologic and psychiatric events that have been experienced by some patients with COVID-19? (0:05)
2. Do we know how the virus could be affecting the central nervous system and peripheral nervous system? (1:46)
3. How can neurologists prepare themselves for these complications? (3:31)
4. Could neurologists learn anything else from your experiences? (4:57)
Speaker disclosure: Angelo Antonini has received honoraria for consultancies, advisory boards and/or speaker activities from: AbbVie, Bial, Boehringer Ingelheim, General Electric, NeuroDerm, UCB and Zambon. He has received research support from: Chiesi, Lundbeck, AbbVie, Horizon 2020 and MIUR.
Support: Interview and filming supported by Touch Medical Media.
Filmed, May 2020.
Related Videos In COVID-19
Hannu Alho – Potential of Ondansetron in Alcohol Use Disorder (Part 2)
Professor Emeritus of Addiction Medicine, Hannu Alho (University of Helsinki, Finland) discusses the need for effective treatment options to manage alcohol use disorder, focusing on odansetron as a newly emerging possibility. Ondansetron is a specific 5HT3-receptor antagonist, which blocks 5HT3 receptors in the gastrointestinal tract and central nervous system, and has been used since the […]
Bengt Winblad, EAN 2020 – Swedish Geriatric Neurologist Perspective on COVID-19
Always a pleasure to catch-up with Editorial Board member, Bengt Winblad (Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden), who chatted with us on several topics including his perspective on the COVID-19 pandemic as a Swedish geriatric neurologist. Question What are your thoughts on the COVID-19 pandemic as a Swedish geriatric neurologist? (0:05) Also see […]
Andrew Chan, EAN 2020 – COVID-19 and Multiple Sclerosis
Great to catch-up with Andrew Chan (Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland), who discussed challenges posed to patient care by COVID-19, factors to consider around immunosuppression for patients with multiple sclerosis (MS) during the pandemic, as well his personal thoughts on exciting developments in MS therapy and the 1st Virtual EAN Congress. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!